Monoclonal antibody therapeutics: history and future.

Abstract

Over the last three decades, monoclonal antibodies have made a dramatic transformation from scientific tools to powerful human therapeutics. At present, approximately 30 therapeutic monoclonal antibodies are marketed in the United States and Europe in a variety of indications, with sales in the US alone reaching approximately $18.5 billion in 2010. This… (More)
DOI: 10.1016/j.coph.2012.08.001

Topics

4 Figures and Tables

Cite this paper

@article{Buss2012MonoclonalAT, title={Monoclonal antibody therapeutics: history and future.}, author={Nicholas A P S Buss and Simon J. Henderson and Mary McFarlane and Jacintha M Shenton and Lolke de Haan}, journal={Current opinion in pharmacology}, year={2012}, volume={12 5}, pages={615-22} }